Company intelligence / Profile preview

BioAnalytics Holdings Pty Ltd

Ownership: Private
Development stage: Other

Overview

BioAnalytics is an Australian medtech company focused on developing and commercializing the iSlpr®, a patented medical device designed to treat obstructive sleep apnea by improving comfort and compliance compared to existing therapies. The product has received regulatory approval in Australia and New Zealand, with plans for expansion into Europe and the US. Early sales are underway in ANZ; broader international commercialization is targeted within 12–24 months. No clinical trial results are cited; efficacy claims are based on regulatory approvals.

Therapeutic areas: Pulmonology
Modalities: Device (mandible-repositioning antisnoring orthosis)Medical device for sleep apnea
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on BioAnalytics Holdings Pty Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAnalytics Holdings Pty Ltd.

Explore the full profile